Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Definition and characterization of the systemic T-cell dysregulation in untreated indolent B-cell lymphoma and very early CLL.

Christopoulos P, Pfeifer D, Bartholomé K, Follo M, Timmer J, Fisch P, Veelken H.

Blood. 2011 Apr 7;117(14):3836-46. doi: 10.1182/blood-2010-07-299321. Epub 2011 Jan 26.

2.

IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.

Mao Z, Quintanilla-Martinez L, Raffeld M, Richter M, Krugmann J, Burek C, Hartmann E, Rudiger T, Jaffe ES, Müller-Hermelink HK, Ott G, Fend F, Rosenwald A.

Am J Surg Pathol. 2007 Oct;31(10):1605-14.

PMID:
17895764
3.

Expansion of effector T cells associated with decreased PD-1 expression in patients with indolent B cell lymphomas and chronic lymphocytic leukemia.

Tonino SH, van de Berg PJ, Yong SL, ten Berge IJ, Kersten MJ, van Lier RA, van Oers MH, Kater AP.

Leuk Lymphoma. 2012 Sep;53(9):1785-94. doi: 10.3109/10428194.2012.673224. Epub 2012 Apr 19.

PMID:
22397719
4.
5.

Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.

Nelson BP, Variakojis D, Peterson LC.

Mod Pathol. 2002 Nov;15(11):1111-20.

6.

Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.

Romano C, De Fanis U, Sellitto A, Dalla Mora L, Chiurazzi F, Giunta R, Rotoli B, Lucivero G.

Leuk Lymphoma. 2003 Nov;44(11):1963-71.

PMID:
14738151
7.
8.

TCL1A expression delineates biological and clinical variability in B-cell lymphoma.

Aggarwal M, Villuendas R, Gomez G, Rodriguez-Pinilla SM, Sanchez-Beato M, Alvarez D, Martinez N, Rodriguez A, Castillo ME, Camacho FI, Montes-Moreno S, Garcia-Marco JA, Kimby E, Pisano DG, Piris MA.

Mod Pathol. 2009 Feb;22(2):206-15. doi: 10.1038/modpathol.2008.148. Epub 2008 Sep 26.

9.

Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia.

Rezvany MR, Jeddi-Tehrani M, Wigzell H, Osterborg A, Mellstedt H.

Blood. 2003 Feb 1;101(3):1063-70. Epub 2002 Oct 3.

10.
11.

Immunophenotypic and DNA genotypic analysis of T-cell and NK-cell subpopulations in patients with B-cell chronic lymphocytic leukaemia (B-CLL).

Frolova EA, Richards SJ, Jones RA, Rawstron A, Master PS, Teasdale J, Short M, Jack AS, Scott CS.

Leuk Lymphoma. 1995 Jan;16(3-4):307-18.

PMID:
7719238
12.
13.

Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.

Almasri NM, Duque RE, Iturraspe J, Everett E, Braylan RC.

Am J Hematol. 1992 Aug;40(4):259-63.

PMID:
1380203
14.
15.

Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.

Di Ianni M, Moretti L, Terenzi A, Bazzucchi F, Del Papa B, Bazzucchi M, Ciurnelli R, Lucchesi A, Sportoletti P, Rosati E, Marconi PF, Falzetti F, Tabilio A.

Cytotherapy. 2009;11(1):86-96. doi: 10.1080/14653240802666035.

PMID:
19153855
16.

CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD).

Jacob MC, Favre M, Lemarc'Hadour F, Sotto MF, Bonnefoix T, Sotto JJ, Bensa JC.

Am J Hematol. 1992 Jan;39(1):45-51.

PMID:
1531569
17.

High expression of the inhibitory receptor BTLA in T-follicular helper cells and in B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.

M'Hidi H, Thibult ML, Chetaille B, Rey F, Bouadallah R, Nicollas R, Olive D, Xerri L.

Am J Clin Pathol. 2009 Oct;132(4):589-96. doi: 10.1309/AJCPPHKGYYGGL39C.

PMID:
19762537
18.

Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.

Bojarska-Junak A, Rolinski J, Wasik-Szczepaneko E, Kaluzny Z, Dmoszynska A.

Haematologica. 2002 May;87(5):490-9.

19.
20.

Abnormal T-cell function in B-cell chronic lymphocytic leukaemia.

Scrivener S, Goddard RV, Kaminski ER, Prentice AG.

Leuk Lymphoma. 2003 Mar;44(3):383-9. Review.

PMID:
12688308

Supplemental Content

Support Center